Professor Lambiase is an expert in cardiac arrhythmias and technologies applied to treat these conditions. His research focuses on arrhythmia mechanisms and randomised trials of therapy-he has pioneered the use of subcutaneous cardiac defibrillators as a minimally invasive therapy. At present he is Chief Investigator of the BHF funded CRAAFT HF randomised trial of atrial fibrillation in heart failure- a partnership of the British Heart Rhythm Society and the British Heart Failure Society co-lead with Professor Mark Petrie. Mechanistic studies are focused on the genetics of arrhythmias and mapping of ventricular tachycardia.
He has co-written ESC Guidelines on SVT 2019, Ventricular Arrhythmias and Prevention of Sudden Death 2022 and published over 350 peer-reviewed papers in Cardiology (Feb 2024 H index 66->39,000 citations). He is an Editor of the Oxford Handbook of Inherited Cardiovascular Disease & Associate Editor European Heart Journal. He is CV Research Co-Director at the Barts Heart Centre.